ZYJ-25e is a histone deacetylase inhibitor (HDACi) with potent orally bioavailable antitumor activities. References: Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer. 2008 Aug 15;123(4):933-41. doi: 10.1002/ijc.23655. PubMed PMID: 18506692.

纯度：≥98%

CAS：1287261-04-4